Laboratoires Delbert Acquires Teralithe 250mg and Teralithe LP 400 from Sanofi.

MANews-(C)2009-2022

France-based pharmaceutical company Laboratoires Delbert has acquired Teralithe 260mg and Teralithe 400mg from Paris-based healthcare provider Sanofi to reinforce its CNS portfolio, the company said.

Laboratoires Delbert financed this acquisition thanks to very strong relationships with its financial partners. Additional terms were not disclosed.

With this acquisition Laboratoires Delbert reinforces the execution of its strategy to ensure safe and continuous availability of Essential...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT